These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 73952)

  • 41. Detection of Bacteroides fragilis and Bacteroides melaninogenicus by indirect immunofluorescence.
    Wang DW; Xiao GX; Zhang YP
    Chin Med J (Engl); 1985 Nov; 98(11):857-8. PubMed ID: 2870883
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunochemical and biologic studies of the lipopolysaccharide of Bacteroides melaninogenicus subspecies asaccharolyticus.
    Mansheim BJ; Onderdonk AB; Kasper DL
    J Immunol; 1978 Jan; 120(1):72-8. PubMed ID: 24073
    [No Abstract]   [Full Text] [Related]  

  • 43. Ultrastructure of Bacteroides species: Bacteroides asaccharolyticus, Bacteroides fragilis, Bacteroides melaninogenicus subspecies melaninogenicus, and B. melaninogenicus subspecies intermedius.
    Woo DD; Holt SC; Leadbetter ER
    J Infect Dis; 1979 May; 139(5):534-46. PubMed ID: 86590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Participation of immunoglobulin and the alternative complement pathway in opsonization of Bacteroides fragilis and Bacteroides thetaiotaomicron.
    Bjornson AB; Bjornson HS
    J Infect Dis; 1978 Sep; 138(3):351-8. PubMed ID: 701850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis.
    Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
    J Clin Pathol; 1985 Jan; 38(1):86-91. PubMed ID: 3881478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VITAMIN K COMPOUNDS IN BACTERIA THAT ARE OBLIGATE ANAEROBES.
    GIBBONS RJ; ENGLE LP
    Science; 1964 Dec; 146(3649):1307-9. PubMed ID: 14207457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Analysis on the distribution and drug resistance features of anaerobes isolated from clinical infectious specimens].
    Wang YY; Han YQ; Guo SF; Fu Q; Wang JR
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2894-2898. PubMed ID: 30293345
    [No Abstract]   [Full Text] [Related]  

  • 48. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bacterial interference by oropharynegeal and clinical isolates of anaerobic bacteria.
    Murray PR; Rosenblatt JE
    J Infect Dis; 1976 Sep; 134(3):281-5. PubMed ID: 10336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenic synergy: mixed intra-abdominal infections.
    MacLaren DM; Namavar F; Verweij-Van Vught AM; Vel WA; Kaan JA
    Antonie Van Leeuwenhoek; 1984; 50(5-6):775-87. PubMed ID: 6397140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. R-plasmid RP1 increases sensitivity of Proteus mirabilis to normal body defences.
    Onaolapo JA; Klemperer RM
    J Med Microbiol; 1987 Nov; 24(3):233-40. PubMed ID: 3312610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Empirical antibiotic therapy of wounds complicated by anaerobic non-clostridial infection].
    Borisova OK; Pavlova MV; Iakovlev VP; Kuleshov SE
    Antibiot Khimioter; 1989 Sep; 34(9):707-11. PubMed ID: 2575366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immunological studies on pyelonephritis -- in vitro phagocytosis of Proteus mirabilis by rat peritoneal macrophages (author's transl)].
    Hirano M
    Nihon Hinyokika Gakkai Zasshi; 1980 Dec; 71(12):1500-14. PubMed ID: 7014960
    [No Abstract]   [Full Text] [Related]  

  • 54. [Functions of intrinsic defense against anaerobic bacteria in healthy probands and patients with chronic-septic granulomatosis].
    Wildfeuer A; Dopfer R; Niethammer D; Galle J; Laufen H; Haferkamp O; Vanek E
    Klin Wochenschr; 1987 Feb; 65(3):113-20. PubMed ID: 3573679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of humoral factors in host resistance to the Bacteroides fragilis group.
    Bjornson AB
    Rev Infect Dis; 1990; 12 Suppl 2():S161-8. PubMed ID: 2406868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anaerobic infection and its rapid detection in surgical patients].
    Zhang Y; Xiao G; Qin X; Li A
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):765-7. PubMed ID: 11829950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative variability in requirements for opsonization of strains within the Bacteroides fragilis group.
    Bjornson AB; Bjornson HS; Ashraf M; Lang TJ
    J Infect Dis; 1983 Oct; 148(4):667-75. PubMed ID: 6631060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potentiation of phagocytosis of Bacteroides fragilis following incubation with clindamycin.
    Howard RJ; Soucy DM
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():63-8. PubMed ID: 6643342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunochemical characterization of surface antigens of Bacteroides melaninogenicus.
    Mansheim BJ; Onderdonk AB; Kasper DL
    Rev Infect Dis; 1979; 1(2):263-77. PubMed ID: 44922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.